These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18710362)

  • 1. Therapeutic potential of icatibant (HOE-140, JE-049).
    Cruden NL; Newby DE
    Expert Opin Pharmacother; 2008 Sep; 9(13):2383-90. PubMed ID: 18710362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Icatibant for hereditary angioedema.
    Gras J
    Drugs Today (Barc); 2009 Dec; 45(12):855-64. PubMed ID: 20135020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Icatibant: HOE 140, JE 049, JE049.
    Drugs R D; 2004; 5(6):343-8. PubMed ID: 15563238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Icatibant as acute treatment for hereditary angioedema in adults.
    Farkas H
    Expert Rev Clin Pharmacol; 2016 Jun; 9(6):779-88. PubMed ID: 27123689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Icatibant: HOE 140, JE 049, JE049.
    Drugs R D; 2005; 6(4):239-44. PubMed ID: 15991885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Switch to icatibant in a patient affected by hereditary angioedema with high disease activity: a case report.
    Firinu D; Barca MP; Serusi L; Lorrai MM; Peralta MM; Manconi PE; Del Giacco SR
    Int J Immunopathol Pharmacol; 2012; 25(1):269-73. PubMed ID: 22507340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema.
    Cicardi M; Banerji A; Bracho F; Malbrán A; Rosenkranz B; Riedl M; Bork K; Lumry W; Aberer W; Bier H; Bas M; Greve J; Hoffmann TK; Farkas H; Reshef A; Ritchie B; Yang W; Grabbe J; Kivity S; Kreuz W; Levy RJ; Luger T; Obtulowicz K; Schmid-Grendelmeier P; Bull C; Sitkauskiene B; Smith WB; Toubi E; Werner S; Anné S; Björkander J; Bouillet L; Cillari E; Hurewitz D; Jacobson KW; Katelaris CH; Maurer M; Merk H; Bernstein JA; Feighery C; Floccard B; Gleich G; Hébert J; Kaatz M; Keith P; Kirkpatrick CH; Langton D; Martin L; Pichler C; Resnick D; Wombolt D; Fernández Romero DS; Zanichelli A; Arcoleo F; Knolle J; Kravec I; Dong L; Zimmermann J; Rosen K; Fan WT
    N Engl J Med; 2010 Aug; 363(6):532-41. PubMed ID: 20818888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy, pharmacokinetics, and safety of icatibant for the treatment of Japanese patients with an acute attack of hereditary angioedema: A phase 3 open-label study.
    Hide M; Fukunaga A; Maehara J; Eto K; Hao J; Vardi M; Nomoto Y
    Allergol Int; 2020 Apr; 69(2):268-273. PubMed ID: 31672405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of acute attacks of hereditary angioedema: potential role of icatibant.
    Longhurst HJ
    Vasc Health Risk Manag; 2010 Sep; 6():795-802. PubMed ID: 20859548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeat treatment with icatibant for multiple hereditary angioedema attacks: FAST-2 open-label study.
    Baş M; Greve J; Hoffmann TK; Reshef A; Aberer W; Maurer M; Kivity S; Farkas H; Floccard B; Arcoleo F; Martin L; Sitkauskiene B; Bouillet L; Schmid-Grendelmeier P; Li H; Zanichelli A
    Allergy; 2013 Nov; 68(11):1452-9. PubMed ID: 24111645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Icatibant for the treatment of hereditary angioedema.
    Cole SW; Lundquist LM
    Ann Pharmacother; 2013 Jan; 47(1):49-55. PubMed ID: 23249729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcutaneous Icatibant for the Treatment of Hereditary Angioedema Attacks: Comparison of Home Self-Administration with Administration at a Medical Facility.
    Otani IM; Lumry WR; Hurwitz S; Li HH; Craig TJ; Holtzman NS; Iandoli MI; Tucker J; Riedl MA; Zuraw BL; Banerji A
    J Allergy Clin Immunol Pract; 2017; 5(2):442-447.e1. PubMed ID: 27818136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Icatibant Outcome Survey: experience of hereditary angioedema management from six European countries.
    Caballero T; Aberer W; Longhurst HJ; Maurer M; Zanichelli A; Perrin A; Bouillet L; Andresen I;
    J Eur Acad Dermatol Venereol; 2017 Jul; 31(7):1214-1222. PubMed ID: 28370444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bradykinin B2-receptor antagonism attenuates fatal cardiocirculatory breakdown induced by severe experimental pancreatitis.
    Yekebas E; Treede H; Jochum M; Gippner-Steppert C; Bloechle C; Knoefel WT; Scholz J; Fink E; Izbicki JR
    Crit Care Med; 2000 Apr; 28(4):1119-27. PubMed ID: 10809293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Icatibant.
    Dubois EA; Cohen AF
    Br J Clin Pharmacol; 2010 May; 69(5):425-6. PubMed ID: 20573077
    [No Abstract]   [Full Text] [Related]  

  • 16. Icatibant , the bradykinin B2 receptor antagonist with target to the interconnected kinin systems.
    Charignon D; Späth P; Martin L; Drouet C
    Expert Opin Pharmacother; 2012 Oct; 13(15):2233-47. PubMed ID: 22970904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population Pharmacokinetics and Exposure-Response Analyses to Guide Dosing of Icatibant in Pediatric Patients With Hereditary Angioedema.
    Wang Y; Jomphe C; Marier JF; Martin P
    J Clin Pharmacol; 2021 Apr; 61(4):555-564. PubMed ID: 33091166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment Effect and Safety of Icatibant in Pediatric Patients with Hereditary Angioedema.
    Farkas H; Reshef A; Aberer W; Caballero T; McCarthy L; Hao J; Nothaft W; Schranz J; Bernstein JA; Li HH
    J Allergy Clin Immunol Pract; 2017; 5(6):1671-1678.e2. PubMed ID: 28601641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Icatibant Outcome Survey: 10 years of experience with icatibant for patients with hereditary angioedema.
    Maurer M; Aberer W; Caballero T; Bouillet L; Grumach AS; Botha J; Andresen I; Longhurst HJ;
    Clin Exp Allergy; 2022 Sep; 52(9):1048-1058. PubMed ID: 35861129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Icatibant.
    Deeks ED
    Drugs; 2010; 70(1):73-81. PubMed ID: 20030426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.